A central problem to evaluating the risk posed by hazardous substances in humans and the environment is a lack of analytical techniques that can handle large sample loads with rapid turn around time. Immunoassays are finding their place among more established methods for measurement of toxic materials in the environment and have a predominant role in human monitoring. Advantages of immunoassays include speed of analysis, cost- effectiveness, sensitivity, specificity, applicability to a wide variety of compounds and adaptability to laboratory or field situations. This proposal has three objectives. The first is to develop rapid, inexpensive assays for hazardous substances and environmental degradation products. Lack of such assays affects site evaluation and limits the development of good models for groundwater movement, human exposure, and research on remediation systems. Several compound classes have been identified for assay development in this proposal. Triazine herbicides are good indicators of agricultural contamination. Assays previously development for parent and metabolic and environmental breakdown products will be used in monitoring studies. The pyrethroids, although of low mammalian toxicity, are toxic to other nontarget organisms such as fish and aquatic invertebrates. Low application rates, lead to very low (but potent) residues making this group of compounds particularly difficult to analyze. The impact of 2,3,7,8-tetrachlorodibenzodioxin on human and environmental health is still subject to debate and is a prime example of a compound for which analysis costs are extremely high. In collaboration with other investigators, assays for naphthalene, and nitronaphthalene will be developed. Heavy metals such as mercury, lead and copper have also been targeted. The second objective is to develop assays to assess human exposure and effect. These assays will be used to probe the mechanistic basis of toxicity. In collaboration with other workers markers for, and the mechanisms of; cellular toxicity will be addressed. Triazine mercapturate and p-nitrophenol (metabolites of some industrial intermediates, explosives and organophosphate insecticides) assays will continue to be validated. Newly proposed targets include a general assay for mercapturates as a marker of exposure to electrophiles, and protein bound species of naphthalene (an example of a target that may be specifically involved in cellular toxicity). Our third objective is the application of new immunochemical technologies to environmental field. The first techniques will interface immunoassay with classical analytical procedures such as utilizing antibodies for affinity separation and cleanup. Use of expert systems in technology transfer will be evaluated. Statistical considerations to address multianalyte problems will be developed. New reporter molecules (such as near IR fluorophores) to improve sensitivity and more robust enzymes to improve shelf life and portability will be evaluated. Finally training and support of other investigators in the use of immunoassay will be provided in collaboration with the Training Core.

Project Start
1999-04-01
Project End
2000-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
13
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Zamuruyev, Konstantin O; Borras, Eva; Pettit, Dayna R et al. (2018) Effect of temperature control on the metabolite content in exhaled breath condensate. Anal Chim Acta 1006:49-60
Zamuruyev, Konstantin O; Schmidt, Alexander J; Borras, Eva et al. (2018) Power-efficient self-cleaning hydrophilic condenser surface for portable exhaled breath condensate (EBC) metabolomic sampling. J Breath Res 12:036020
Philippat, Claire; Barkoski, Jacqueline; Tancredi, Daniel J et al. (2018) Prenatal exposure to organophosphate pesticides and risk of autism spectrum disorders and other non-typical development at 3 years in a high-risk cohort. Int J Hyg Environ Health 221:548-555
Burmistrov, Vladimir; Morisseau, Christophe; Pitushkin, Dmitry et al. (2018) Adamantyl thioureas as soluble epoxide hydrolase inhibitors. Bioorg Med Chem Lett 28:2302-2313
Wang, Weicang; Yang, Jun; Zhang, Jianan et al. (2018) Lipidomic profiling reveals soluble epoxide hydrolase as a therapeutic target of obesity-induced colonic inflammation. Proc Natl Acad Sci U S A 115:5283-5288
Tu, Ranran; Armstrong, Jillian; Lee, Kin Sing Stephen et al. (2018) Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia. Sci Rep 8:5279
Hill 3rd, Thomas; Rice, Robert H (2018) DUOX expression in human keratinocytes and bronchial epithelial cells: Influence of vanadate. Toxicol In Vitro 46:257-264
Taha, Ameer Y; Hennebelle, Marie; Yang, Jun et al. (2018) Regulation of rat plasma and cerebral cortex oxylipin concentrations with increasing levels of dietary linoleic acid. Prostaglandins Leukot Essent Fatty Acids 138:71-80
Kodani, Sean D; Wan, Debin; Wagner, Karen M et al. (2018) Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors. ACS Omega 3:14076-14086
Ren, Qian; Ma, Min; Yang, Jun et al. (2018) Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease. Proc Natl Acad Sci U S A 115:E5815-E5823

Showing the most recent 10 out of 1149 publications